- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Tutankhamun’s Antimalarial Drug for Covid-19 ; year:2020
Drug research ; (2020)
- Contributor
-
Sommer, Andrei P.
Försterling, Horst-Dieter
Sommer, Katlin E.
- DOI
-
10.1055/a-1274-1264
- URN
-
urn:nbn:de:101:1-2020122113001045282045
- Rights
-
Kein Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:22 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Sommer, Andrei P.
- Försterling, Horst-Dieter
- Sommer, Katlin E.
Other Objects (12)
Antimalarial herbal drugs: a review of their interactions with conventional antimalarial drugs
Hydroxychloroquine – An Antimalarial to Fight COVID-19?
Effects of Antimalarial Drugs on Neuroinflammation-Potential Use for Treatment of COVID-19-Related Neurologic Complications
Antimalarial drugs: unexpected evolutionary consequences
World Antimalarial Resistance Network I: Clinical efficacy of antimalarial drugs
Drug resistance genomics of the antimalarial drug artemisinin
World Antimalarial Resistance Network (WARN) II: In vitro antimalarial drug susceptibility
Antimalarial drugs—are they beneficial in rheumatic and viral diseases?—considerations in COVID-19 pandemic
A database of antimalarial drug resistance
The threat of antimalarial drug resistance
Unlocking Nanocarriers for the Programmed Release of Antimalarial Drugs
The global challenge of antimalarial drug resistance
Antimalarial herbal drugs: a review of their interactions with conventional antimalarial drugs
Hydroxychloroquine – An Antimalarial to Fight COVID-19?
Effects of Antimalarial Drugs on Neuroinflammation-Potential Use for Treatment of COVID-19-Related Neurologic Complications
Antimalarial drugs: unexpected evolutionary consequences
World Antimalarial Resistance Network I: Clinical efficacy of antimalarial drugs
Drug resistance genomics of the antimalarial drug artemisinin
World Antimalarial Resistance Network (WARN) II: In vitro antimalarial drug susceptibility
Antimalarial drugs—are they beneficial in rheumatic and viral diseases?—considerations in COVID-19 pandemic
A database of antimalarial drug resistance
The threat of antimalarial drug resistance
Unlocking Nanocarriers for the Programmed Release of Antimalarial Drugs
The global challenge of antimalarial drug resistance
Antimalarial herbal drugs: a review of their interactions with conventional antimalarial drugs
Hydroxychloroquine – An Antimalarial to Fight COVID-19?
Effects of Antimalarial Drugs on Neuroinflammation-Potential Use for Treatment of COVID-19-Related Neurologic Complications
Antimalarial drugs: unexpected evolutionary consequences
World Antimalarial Resistance Network I: Clinical efficacy of antimalarial drugs
Drug resistance genomics of the antimalarial drug artemisinin
World Antimalarial Resistance Network (WARN) II: In vitro antimalarial drug susceptibility
Antimalarial drugs—are they beneficial in rheumatic and viral diseases?—considerations in COVID-19 pandemic
A database of antimalarial drug resistance
The threat of antimalarial drug resistance
Unlocking Nanocarriers for the Programmed Release of Antimalarial Drugs